KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Paolo Lazzari, Marco Spiga, Monica Sani, Matteo Zanda, Ian N Fleming

Research output: Contribution to journal › Article › peer-review

12 Downloads (Pure)

1 results
- Last Name(descending)

Ian Fleming
- School of Medicine, Medical Sciences & Nutrition, Medical Education - Senior Lecturer (Scholarship)
- School of Medicine, Medical Sciences & Nutrition, Aberdeen Biomedical Imaging Centre
Person: Academic Related - Scholarship